Ugur Sahin is the sole shareholder of a German company that controls an 18% stake in BioNTech. Highlight BioNTech co-founder Ugur Sahin joined the 500 richest people in the world BioNTech shares rose 8% this week, more than 250% on the year The German firm, focused on the fight against …
Read More »
Investors then delved into the data. BioNTech was founded in 2008 but had little to show for its work, some investors concluded. At that time, only 250 patients had been treated with the company’s vaccines. Others doubted that BioNTech was better than Moderna Inc., a rival using similar technology, whose …
Read More »
October is a critical month in the race for a Covid-19 vaccine, with developments that could lead to some Americans getting vaccinated in the final days of 2020. Pfizer Inc. and German partner BioNTech SE plan this month to reveal the results of the last stage showing whether or not …
Read More »